CytomX Therapeutics Inc (CTMX) — Free Cash Flow Generation Index
CytomX Therapeutics Inc (CTMX) has a Free Cash Flow Generation Index of 0.99x as of March 2023. Free cash flow of $9.30 Million represents 1% of operating cash flow ($9.35 Million). See working capital to net assets of CytomX Therapeutics Inc to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
CytomX Therapeutics Inc Free Cash Flow Generation Index (2014–2020)
Historical FCF Generation Index trend for CytomX Therapeutics Inc across 3 annual periods. Explore CytomX Therapeutics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for CytomX Therapeutics Inc (2014–2020)
Year-by-year Free Cash Flow Generation Index for CytomX Therapeutics Inc. For the full company profile including market capitalisation, see CTMX market cap overview.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.56x | $2.95 Million | $5.26 Million | $2.31 Million | ▼ -43.4% |
| 2017 | 0.99x | $168.81 Million | $170.37 Million | $1.56 Million | ▲ +4.6% |
| 2014 | 0.95x | $30.14 Million | $31.80 Million | $1.66 Million | — |